APA način citiranja

Yu, I. S., & Loree, J. M. (2021). FOLFOXIRI plus Bevacizumab Versus FOLFOX plus Panitumumab for Metastatic Left‐Sided RAS/BRAF Wild‐Type Colorectal Cancer: Which “Side” Are You On? Oncologist.

Čikaški stil citiranja

Yu, Irene S., i Jonathan M. Loree. "FOLFOXIRI Plus Bevacizumab Versus FOLFOX Plus Panitumumab for Metastatic Left‐Sided RAS/BRAF Wild‐Type Colorectal Cancer: Which “Side” Are You On?" Oncologist 2021.

MLA način citiranja

Yu, Irene S., i Jonathan M. Loree. "FOLFOXIRI Plus Bevacizumab Versus FOLFOX Plus Panitumumab for Metastatic Left‐Sided RAS/BRAF Wild‐Type Colorectal Cancer: Which “Side” Are You On?" Oncologist 2021.